Abstract
Epstein-Barr virus (EBV) was used to immortalize human peripheral B lymphocytes committed to the productio of autoantibodies in healthy subjects and in patients with various autoimmune diseases. EBV-transformed B lymphocytes producing human monoclonal autoantibodies were fused with the human-mouse heterohybridoma F3B6 cells to stabilize the production of monoclonal antibodies (mAb). The present method of generating human B cell clones producing mAbs now makes it possible to analyze in detail the nature of human autoantibodies with respect to antigen-binding specificity, affinity, corresponding autoepitopes, and the variable (V) region structure.
Original language | English (US) |
---|---|
Pages (from-to) | 159-168 |
Number of pages | 10 |
Journal | ImmunoMethods |
Volume | 1 |
Issue number | 3 |
DOIs | |
State | Published - Dec 1992 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology